换一批Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
第一作者：
Betül,Oran
第一单位：
Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: boran@mdanderson.org.
作者：
Betül,Oran [1]
;
Kwang Woo,Ahn [2]
;
Caitrin,Fretham [3]
;
Amer,Beitinjaneh [4]
;
Asad,Bashey [4]
;
Attaphol,Pawarode [5]
;
Baldeep,Wirk [6]
;
Bart L,Scott [7]
;
Bipin N,Savani [8]
;
Christopher,Bredeson [9]
;
Daniel,Weisdorf [10]
;
David I,Marks [11]
;
David,Rizzieri [12]
;
Edward,Copelan [13]
;
Gerhard C,Hildebrandt [14]
;
Gregory A,Hale [15]
;
Hemant S,Murthy [16]
;
Hillard M,Lazarus [17]
;
Jan,Cerny [18]
;
Jane L,Liesveld [19]
;
Jean A,Yared [20]
;
Jean,Yves-Cahn [21]
;
Jeffrey,Szer [22]
;
Leo F,Verdonck [23]
;
Mahmoud,Aljurf [24]
;
Marjolein,van der Poel [25]
;
Mark,Litzow [26]
;
Matt,Kalaycio [27]
;
Michael R,Grunwald [13]
;
Miguel Angel,Diaz [28]
;
Mitchell,Sabloff [29]
;
Mohamed A,Kharfan-Dabaja [16]
;
Navneet S,Majhail [30]
;
Nosha,Farhadfar [31]
;
Ran,Reshef [32]
;
Richard F,Olsson [33]
;
Robert Peter,Gale [34]
;
Ryotaro,Nakamura [35]
;
Sachiko,Seo [36]
;
Saurabh,Chhabra [37]
;
Shahrukh,Hashmi [38]
;
Shatha,Farhan [39]
;
Siddhartha,Ganguly [40]
;
Sunita,Nathan [41]
;
Taiga,Nishihori [42]
;
Tania,Jain [43]
;
Vaibhav,Agrawal [44]
;
Ulrike,Bacher [45]
;
Uday,Popat [46]
;
Wael,Saber [47]
作者单位：
Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: boran@mdanderson.org.
[1]
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
[2]
Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.
[3]
Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.
[4]
Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Mchigan.
[5]
Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
[6]
Fred Hutchinson Cancer Research Center, Seattle, Washington.
[7]
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
[8]
The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
[9]
Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
[10]
Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
[11]
Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
[12]
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
[13]
Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
[14]
Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
[15]
Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
[16]
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
[17]
Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.
[18]
Department of Medicine, University of Rochester Medical Center, Rochester, New York.
[19]
Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland.
[20]
Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
[21]
Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
[22]
Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
[23]
Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
[24]
Maastricht University Medical Centre, Maastricht, The Netherlands.
[25]
Division of Hematology and Transplant Center, Mayo Clinic, Rochester, Minnesota.
[26]
Hematology and Medical Oncology, Transplantation Center, Cleveland Clinic, Cleveland, Ohio.
[27]
Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
[28]
Division of Hematology, Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
[29]
Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
[30]
Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
[31]
Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
[32]
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
[33]
Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
[34]
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
[35]
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
[36]
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
[37]
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
[38]
Henry Ford Hospital Bone Marrow Transplant Program, Henry Ford Health System, Detroit, Michigan.
[39]
Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
[40]
Rush University Medical Center, Chicago, Illinois.
[41]
Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
[42]
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland.
[43]
Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
[44]
Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
[45]
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
[46]
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
[47]
医学主题词
老年人(Aged);白消安(Busulfan);移植物抗宿主病(Graft vs Host Disease);人类(Humans);美法仑(Melphalan);中年人(Middle Aged);骨髓增生异常综合征(Myelodysplastic Syndromes);存活率分析(Survival Analysis);移植预处理(Transplantation Conditioning);阿糖腺苷(Vidarabine)
DOI
10.1016/j.jtct.2021.08.007
PMID
34403791
发布时间
2022-11-02
- 浏览2
Transplantation and cellular therapy
Transplantation and cellular therapy
2021年27卷11期
921.e1-921.e10页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
